Z
Live / Registered — Registered — Section 8 accepted (as of 05 Oct 2023)
What this means for you
Registered since 31 Oct 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86923538
- Registration number
- 5324651
- Mark type
- Design + words
- Filed
- 29 Feb 2016
- Published for opposition
- 03 Jan 2017
- Registered
- 31 Oct 2017
Goods and services
- Class 042 — Scientific and technological services: Bacteriological consultation and research; Bacteriological research; Bacteriological research and testing; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Compiling data for research purposes in the field of medical science and medical consultancy; Conducting clinical trials for others in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Custom design and development of chemical reagents and biochemical assays; Design and testing of new products for others; Development of pharmaceutical preparations and medicines; Diagnostic services in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Drug discovery services; Genetic mapping for scientific purposes; Genetic testing for scientific research purposes; Genotyping services for research or analysis purposes; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of medical imaging; Medical and scientific research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research information in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Medical and scientific research, namely, conducting clinical trials for others; Medical research; Medical research services in the field of cancer; Pharmaceutical drug development services; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products for others; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Scientific investigations for medical purposes; Scientific laboratory services; Scientific research and development; Scientific research consulting in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of oncology, rheumatoid arthritis, diabetes and metabolic disorders; Scientific research in the field of genetics and genetic engineering; Scientific research in the field of oncology; Scientific study and research in the field(s) of rheumatoid arthritis; Scientific study and research in the field(s) of diabetes; Scientific study and research in the field(s) of metabolic disorders; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies
Owner
- Zumutor Biologics Inc, Cambridge, MA, US
- Zumutor Biologics Inc, Woburn, MA, US
- Zumutor Biologics Inc, Woburn, MA, US
Prosecution history
- 05 Oct 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Oct 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 05 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 May 2023 — TEAS SECTION 8 RECEIVED
- 31 Oct 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 31 Oct 2017 — REGISTERED-PRINCIPAL REGISTER
- 27 Sept 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 26 Sept 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 20 Sept 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 28 Aug 2017 — USE AMENDMENT FILED
- 14 Sept 2017 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Aug 2017 — TEAS STATEMENT OF USE RECEIVED
- 28 Feb 2017 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 03 Jan 2017 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 03 Jan 2017 — PUBLISHED FOR OPPOSITION